Model
Edge
PDL BioPharma, Inc.
0000882104
Filing Type
8-K
Filing Date
12/7/2020
Updated
12/8/20, 9:07 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Board, Management or Compensation
EX-99.1
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Board, Management or Compensation
GRAPHIC
LOGO